Why can patients with diabetes develop symptomatic hypoglycaemia after starting sofosbuvir + velpatasvir?

Patients with diabetes can develop symptomatic hypoglycaemia after starting sofosbuvir + velpatasvir because direct-acting antiviral treatment may improve glucose control, so glucose should be closely monitored, particularly during the first three months, and diabetes treatment adjusted when necessary.